Results 51 to 60 of about 138,331 (318)
Background The efficacy and safety of bariatric surgery have not been fully elucidated in patients affected with human immunodeficiency virus. Although adjustable gastric banding and sleeve gastrectomy are starting to be used in patients with human ...
Wei Yang +7 more
doaj +1 more source
Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms [PDF]
Yu Ji +7 more
openalex +1 more source
Splenic and concomitant liver abscess after laparoscopic sleeve gastrectomy [PDF]
Introduction: Laparoscopic sleeve gastrectomy (LSG) is a safe and effective procedure for losing weight and gaining control of obesity-related comorbidities.
Avallone, Marcello +3 more
core +1 more source
Use of glucagon‐like peptide‐1 receptor agonists in patients with left ventricular assist devices
Key question: does GLP1‐RA therapy improve heart transplantation rates and clinical outcomes in patients with LVADs? Key findings: in this propensity score‐matched cohort study of 1068 LVAD recipients, GLP1‐RA use was associated with higher heart transplantation rates (18.9% vs.
Ramzi Ibrahim +12 more
wiley +1 more source
To evaluate the efficacy and nutrition of single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) in Chinese obese patients in the first postoperative year.
Lifu Hu +9 more
doaj +1 more source
Background and Objectives: Obesity and gastroesophageal reflux disease (GERD) are steadily increasing world weight and antireflux surgery must be performed simultaneously with bariatric surgery in obese patients.
Oral Ospanov +6 more
doaj +1 more source
Background Enhanced recovery after surgery (ERAS) programmes have led to a decreased duration of hospital stay in several surgical fields, but have not been fully tested in patients undergoing laparoscopic Roux‐en‐Y gastric bypass (LRYGB) for obesity ...
N. Geubbels +6 more
doaj +1 more source
Outcomes and Adverse Events After Bariatric Surgery: An Updated Systematic Review and Meta-analysis, 2013–2023 [PDF]
Jane Chungyoon Kim +9 more
openalex +1 more source
There is growing clinical interest in strategies for improving clinical outcomes in patients with heart failure (HF) and obesity. The development of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and of the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 RA has expanded therapeutic options for this population. This expert consensus
Luca Monzo +13 more
wiley +1 more source
This study aimed to retrospectively analyze the perioperative and postoperative follow-up data of patients with super obesity who had undergone RYGB, SG, BPD/DS, and SADI-S.
Zheng Zhang +5 more
doaj +1 more source

